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Abstract
Background: Implementing evidence-based chronic disease prevention with a practice-wide population is challenging
in primary care.
Methods: PEP Intervention practices received education, clinical audit and feedback and practice facilitation.
Patients (40‑69 years) without chronic disease from trial and control practices were invited to participate in baseline and
12 month follow up questionnaires.
Patient-recalled receipt of GP services and referral, and the proportion of patients at risk were compared over time and
between intervention and control groups. Mean difference in BMI, diet and physical activity between baseline and follow
up were calculated and compared using a paired t-test. Change in the proportion of patients meeting the definition for
physical activity diet and weight risk was calculated using McNemar’s test and multilevel analysis was used to determine
the effect of the intervention on follow-up scores.
Results: Five hundred eighty nine patients completed both questionnaires. No significant changes were found in the
proportion of patients reporting a BP, cholesterol, glucose or weight check in either group. Less than one in six at-risk
patients reported receiving lifestyle advice or referral at baseline with little change at follow up. More intervention patients
reported attempts to improve their diet and reduce weight. Mean score improved for diet in the intervention group
(p = 0.04) but self-reported BMI and PA risk did not significantly change in either group. There was no significant change
in the proportion of patients who reported being at-risk for diet, PA or weight, and no changes in PA, diet and BMI in
multilevel linear regression adjusted for patient age, sex, practice size and state. There was good fidelity to the
intervention but practices varied in their capacity to address changes.
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Conclusions: The lack of measurable effect within this trial may be attributable to the complexities around behaviour
change and/or system change. This trial highlights some of the challenges in providing suitable chronic disease preventive
interventions which are both scalable to whole practice populations and meet the needs of diverse practice structures.
Trial registration: Australian and New Zealand Clinical Trials Registry (ANZCTR): ACTRN12612000578808 (29/5/2012). This
trial registration is retrospective as our first patient returned their consent on the 21/5/2012. Patient recruitment was
ongoing until 31/10/2012.
Keywords: Primary health care, Family practice, Primary prevention, Delivery of health care, Quality improvement; practice
guidelines, Evidence based medicine, Cardiovascular disease
Background
The provision of effective preventive care aims to re-
duce preventable morbidity and mortality, enhance
quality of life and decrease an individual’s need gener-
ally for medical services [1]. As people age, having
favourable risk factor levels not only decreases the
lifetime risk of developing a chronic illness, it also in-
creases survival should a chronic condition occur [2].
Primary care can provide a routine range of prevent-
ive activities including opportunistic screening and
risk factor identification [3], and general practitioners
(GPs) can positively influence their patient’s lifestyle
choices, and encourage and equip them to take a
greater interest in, and greater responsibility for, their
own health [4]. In practice, however, few primary care
encounters in Australia involve risk-factor assessment
and intervention [5].
Australian health policy encourages general practice to
routinely incorporate prevention [6, 7] via a range of ini-
tiatives provided through the national health insurance
scheme, Medicare. These fund or incentivise primary
care-based prevention activities including health checks
for specific age groups and at-risk populations, and the
utilisation of practice nurses (PNs) to conduct health
assessments [8].
Clinical guidelines which provide evidence based rec-
ommendations for clinical management and early identi-
fication and management of biomedical risk factors such
as obesity, high blood pressure, high blood cholesterol
and impaired glucose tolerance further support general
practice to undertake prevention [9–11]. Although GPs
generally accept such guidelines, significant barriers have
been identified to the uptake and implementation of
these [12–14].
Patients also report some barriers when seeking
preventive care such as limited consultation time, a
focus by the GP on acute health care issues as opposed
to prevention, and receipt of superficial preventive
advice without sufficient follow up or exploration of the
personal or behavioural mechanisms associated with
continued risk behaviour [15].
Strategies that have been found to effectively aid the
implementation of guidelines in general practice include
small group education for providers, clinician prompts
and decision aids, audit and feedback and external facili-
tation [16]. Practice facilitation is a supportive service
utilising a range of organisational development, project
management, quality improvement (QI), and practice
improvement approaches to build internal capacity, en-
abling the engagement in activities which provide
support over time to achieve incremental and trans-
formative improvement goals [17]. Practice facilitation is
a promising method to overcome organisational or
system level barriers to evidence translation [18] where
trained external facilitators, not involved in direct
patient care, are used to support practices to implement
changes that will improve the quality of the care they
provide [19, 20]. The advantage of practice facilitation is
that it allows programs to be tailored to individual prac-
tice situations [21] and it supports practice redesign
[22], resulting in more sustainable work practices [21]
and increased internal capacity [20]. A systematic review
by Baskerville, found primary care practices to be more
than twice as likely to adopt evidence-based guidelines
through practice facilitation [18]. There is also some evi-
dence that practice facilitation leads to improvements in
quality of care [22] and levels of preventive care [21].
The Preventive Evidence into Practice (PEP) study was
a cluster randomised trial implemented concurrently in
four Australian states during 2012/2013. The trial evalu-
ated the effectiveness of a model of education, clinical
audit and feedback and practice facilitation that aimed
to improve the implementation of vascular disease pre-
vention guidelines in Australian general practice. Previ-
ously published data from this trial includes clinical
record audit data for 21,848 patients and survey data
from general practitioners (GPs) and practice nurses.
Outcomes reported include recording rates for smoking,
alcohol intake, body mass index (BMI), waist circumfer-
ence and blood pressure for deidentified patients aged
45–69 years and lipids, fasting blood glucose and cardio-
vascular risk for those aged 40–69 years; and change in
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self-reported frequency and confidence of clinicians in
conducting assessments for their patients [23].
The aim of this paper is to provide base-line and 12
month questionnaire data for patients who were recruited
from general practices participating in the PEP trial.
Methods
Design, eligibility and recruitment
The trial design has been previously reported [24]. Six-
teen practices were assigned to receive the PEP interven-
tion and 16 provided usual care. A random sample of
160 patients from each practice was identified using
PenCat clinical audit software. Eligible patients were 40–
69 years without known diabetes, cardiovascular disease
or renal impairment, and who had visited a study prac-
tice within the last year. Practice staff vetted the patient
list to ensure that only those patients with proficient
English and cognitive awareness were approached. Add-
itional exclusion criteria included severe mental illness,
substance abuse or pregnancy. Eligible patients received
a mailed invitation, and those willing to participate,
returned their consent to the PEP study centre at the
University of New South Wales. Study questionnaires
were mailed at baseline and 12 months.
The PEP practice intervention
The PEP trial was designed to address known evidence-
practice gaps in chronic disease prevention in general
practice. These include substantial undertreatment and
low rates of appropriate treatment in patients at high
risk of a cardiovascular event [25, 26]; poor recording of
BMI and waist circumference [27] and suboptimal
assessment of lifestyle risk factors including smoking
status, alcohol intake, diet and weight [28]. Other gaps
include appropriate advice and referral to deal with life-
style risk. Research suggest that less than a third of over-
weight and obese patients in general practice receive some
form of lifestyle assistance (diet or exercise) for weight loss
from their GP [29] and referral rates for educational or
behavioural interventions are generally low [30, 31].
The practice level intervention targeted the clinical
management of patients by both GPs and PNs and
aimed to promote evidence based preventive care of
patients who smoke, drink excessive alcohol, have a poor
diet, are physically inactive, are obese or have a risk of
cardiovascular disease or diabetes. A synthesis of major
guideline recommendations for the prevention of vascu-
lar disease from the National Vascular Disease Preven-
tion Alliance (NVDPA) [11], the Royal Australian
College of General Practitioners (RACGP) [9] and the
National Health and Medical Research Council
(NHMRC) [10] of Australia were synthesise across the
5As framework and provided to each intervention prac-
tice as a quick reference guide (Fig. 1).
This framework (Assess, advise/Agree, Assist/Arrange)
provides a brief intervention model for the delivery of
preventive care in primary health care including the
process of behaviour change for patients [24]. This
framework has been incorporated into a range of clinical
practice guidelines [25], and the guidance for clinical
care and organisation of general practice in relation to
behavioural risk factors by the Royal Australian College
of General Practitioners (RACGP) [9].
The intervention comprised the following:
1. Clinician education – Clinicians received three hours
of interactive, small group education. At these
sessions, the preventive evidence reference guide was
provided with presentations as to the
recommendations within the guidelines. The
education sessions also explored aspects of readiness
to change and sought to equip the clinicians with
specific skills in motivational interviewing and brief
behaviour change techniques with their patients.
2. Audit and feedback – practices underwent a de-
identified clinical audit of their data and received
feedback reports which highlighted issues with re-
cording and provided recommendations to improve
this.
3. Practice facilitation visits –Intervention Facilitators
(IFs) were sourced from local primary care
organisations (Medicare Local) where they had roles
undertaking QI activities with general practice.
Facilitators underwent a 1 day training session with
the study investigators and were supervised and
supported through the intervention by the study
investigators and study coordinator. Facilitators used
each practice’s clinical audit report to identify specific
areas of need for the practice and to identify
organisational, clinical, and business functions of the
practice that could be improved to support improved
preventive care (i.e. changes/clarification to staff roles
and activities). They assisted with the identification of
a ‘practice prevention coordinator’ and other changes
to practice systems and resources (e.g. use of
assessment tools, correct recording and ordering of
specific education materials). A locally relevant
information directory was also provided to practices
comprising associated community services,
providers or programs (e.g. phone advice lines,
exercise programs). The facilitator reviewed usual
practice and advised about Medicare-funded items
that support preventive care visits, the identifica-
tion of high risk patients, and systems to support
patient recall. Three practice facilitation visits of
1‑2 h each were provided as well as follow up
phone calls between visits to keep practices en-
gaged with the facilitation process.
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Study logic and rationale
The study logic model (Fig. 2) was also developed
around the 5As. The main assumption within the
model was that increased access to preventive evi-
dence provided via the reference guide and reiterated
through the education and facilitation, would encour-
age clinicians to improve their preventive practices
(increased screening and the use of tools to identify
at-risk patients; increased recall, referral, recording
and better clinical management).We also hypothesised
that this would result in improved patient/provider
interaction resulting in a reduction in both risk be-
haviour and physiological risk over the 12-month
period of the trial.
Fig. 1 PEP prevention Reference Guide
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Study outcomes
Outcomes assessed were all self-reported patient
outcomes. These included impacts on lifestyle risk (and
stage of readiness to change), impact on preventive care
received, use of GP services and level of advice and
referral received from their practice.
Patient data collection instrument and management of
data
The PEP patient questionnaire has been used in previous
research by the authors [32]. It utilised items from the
NSW Adult Heath Survey [33] and the National Health
Survey [34]. The content of the NSW Adult Health
Survey was initially developed in consultation with NSW
Area Health Services (AHS), government departments,
and a range of experts. The content was designed to cover
the eight health priority areas for NSW (asthma, Diabetes,
Cardiovascular health, Mental health, injury prevention,
arthritis and musculoskeletal conditions, Dementia) [35]
and was translated into a number of languages. The Na-
tional Health Survey is designed to obtain national bench-
mark information on a range of health-related issues and
to enable the monitoring of trends in health over time
[34] and is regularly administered by the Australian Bur-
eau of Statistics (ABS). Other validated instruments were
also incorporated within the PEP questionnaire to meas-
ure health literacy (Health Literacy Management Scale)
[36] and health related quality of life (SF12) [37]. These
outcomes have been reported separately [38].
The questionnaire asked patients for personal demo-
graphic information and self-reported information about
diet, smoking and levels of PA, and attempts to change
these within the last 3 months. Respondents were asked
to recall whether they had received preventive care in
the 3 months prior to the data collection time points.
This included the total number of visits to their GP, the
number of health checks undertaken and whether blood
pressure, blood cholesterol and blood sugar and weight
had been assessed during consultation. Patients also
reported any advice they recalled being given by their GP
concerning alcohol use, smoking cessation, healthy eating,
weight control, elevated cholesterol or blood pressure and
general prevention of diabetes and heart disease. Informa-
tion on referral to attend lifestyle related health programs
for any of these issues was also collected, as was patient
reported attendance due to referral.
We used the Transtheoretical Model of Change [39] to
categorise patient ‘readiness to change’. Patients self-
reported across six categories of health-related behav-
iour: eating more fruit and vegetables; eating less dietary
fat; doing more physical activity; drinking less alcohol;
losing weight and stopping smoking. Their responses
were assessed against the stages of ‘pre-contemplation’,
‘contemplation’, ‘action’ and ‘maintenance’ [40], Contem-
plation was intent to change behaviour within the next
1‑6 month period, action included those who were cur-
rently taking measures to change, and maintenance were
those who had already changed their behaviour, and had
maintained this change for the previous 6 months.
Smoking and alcohol consumption were assessed
across two categories (smoker/non-smoker; and 2 or
less/more than 2 standard drinks per day). A PA score
was calculated based on the weekly frequency of doing
vigorous and/or moderate physical activity and a range
for individuals was calculated (from 0 to 8) with a score
of four or less considered at-risk [41]. Diet score was the
number of serves of fruit and vegetables consumed in an
average day with six or less serves being considered at-
risk [10], and BMI was calculated from patient reported
weight and height with at-risk being 25 and higher [11].
Fig. 2 PEP study logic model
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Patient questionnaires were checked for consistency
and logged at the University of New South Wales
(UNSW) study centre before being externally scanned.
Data sets underwent cleaning and re-coding and the
data belonging to participants who had completed the
questionnaire at both timepoints were matched. Analysis
was undertaken using SPSS Statistics 22.
Analysis
Patient questionnaire
Patient demographic characteristics were assessed for
variability at baseline. Further analysis was conducted on
589 patients who completed baseline and follow up
questionnaires.
We compared change over time and change between
intervention and control groups at baseline and
12 months for patient-recalled receipt of GP services
and referral. In assessing ‘readiness to change’, the
proportion of patients in the action and maintenance
categories with risk factors was compared between inter-
vention and control at baseline and at 12 months. Data
was missing for 1–2% of questions (with no differences
between intervention and control groups). Patients with
missing data were included in the denominator for
calculating risk rates.
For BMI, diet and PA scores, mean differences be-
tween baseline and follow up were calculated and com-
pared using a paired t-test. Change in the proportion of
patients meeting the definition for PA, diet and weight
risk was calculated using McNemar’s test and compared
between intervention and control groups at both time
points. Multilevel analysis was performed using MLwiN
version 2.25 [42] to determine the effect of the interven-
tion on follow up scores after adjustment for baseline
scores and other covariates. Two-sided p-values of less
than 0.05 were considered statistically significant.
Assessing fidelity of the PEP intervention
The PEP intervention was a multi-component inter-
vention delivered at the practice level. When conduct-
ing research in general practice there are several ‘real
world’ contextual issues that make the delivery of a
controlled intervention challenging. Practices vary in
their structure and processes, and the available time
to undertake research. Each will have different levels
of motivation to participate in research and each clin-
ician will have a different level of interest and skill in
delivering research based activities. Within this study,
we assessed if the components of the PEP interven-
tion were administered to practices (i.e. as per study
protocol). This included the number of practices
where enrolled clinicians attended the education ses-
sions and the number of practices that participated in
facilitation visits and follow up phone calls. This was
tabulated and we calculated the mean length (in
weeks) that it took to implement the facilitation com-
ponent of the intervention to practices in each state
and compared these across the 4 states.
Qualitative interviews with facilitators were used to as-
sess if there were variations within the facilitation pro-
cesses, to gauge their experiences working with
practices, and any factors that they perceived to have im-
pacted on the practices ability to implement the PEP
intervention. Each facilitator kept a record (diary) of
each practice visit and phone call. These reports docu-
mented short and long-term practice goals and relevant
activities undertaken at the practice via a template struc-
tured around the chronic care model. This also provided
opportunities to document perceived challenges and
barriers to change within each practice.
Qualitative interviews conducted with GPs and PNs
about the facilitation process were used to enhance
our understanding around the patient responses
particularly in relation to the preventive care received
from their GP. This interview data was collected in
NVivo and common factors and themes were drawn
out and summarised. Feedback from GPs from the
process used to allocate professional development
points for the activity was also reviewed to ascertain
the perceived quality of care that GPs felt they were
providing, including their specific learnings from the
project.
Results
Fidelity of the intervention
There was reasonable fidelity to the PEP intervention
determined by practice participation in education and
facilitation sessions (Table 1). All intervention practices
apart from the one excluded practice (Victoria), partici-
pated in the clinical education sessions. Training was
not always achieved through the state-based project
workshops. In some instances, supplementary education



































a1 practice excluded due to IT incompatibility issue
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sessions were provided as group sessions at individual
practices, or on a one-to one basis.
The full complement of facilitator visits (n = 3) and
follow up phone calls were delivered across all
practices except in one state (Queensland) where
facilitators were not able to contact any of the three
intervention practices for the first phone call. We
planned to provide the intervention over a 12-week
period, but in fact the length of the facilitation
ranged from eight to nineteen weeks. In those prac-
tices where the facilitation took longer, this was due
to several factors ranging from non-availability of
clinical staff, unexpected staff turnover and practice
closures over the Christmas holiday period. Data
from 46 of the 70 participating GPs (66%) indicated
that the learning component of the study was gener-
ally well received by GPs with more GPs (70%) than
not (30%) reporting that their learning objectives and
learning needs had been met by the study.
Impact on practice organisation
The objectives identified during facilitation were very
similar with no overt variance noted by state or facili-
tator. Due to sub-optimal levels of recording
Fig. 3 PEP CONSORT flow diagram
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identified from many of the practice audits, a major
goal identified by many practices was the improved
assessment and recording of height, weight, BMI, waist
circumference, alcohol use, smoking status and diabetes
risk through administration of the AUSDRISK (Australian
Type 2 Diabetes risk assessment tool). Some practices
also aimed to increase the use of the absolute cardio-
vascular risk tool, and one practice aimed for a
monthly focus on lifestyle change and the establish-
ment of a walking group.
GPs reported that the audit had heightened their
awareness of the need to screen their patients between
40‑69 years more thoroughly, and to improve their sys-
tems to correctly identify those patients requiring pre-
ventive care. Many had noticed shortfalls in their
recording particularly around alcohol intake and smok-
ing status, and had recognised a need to ask patients
about their substance use, and provide opportunistic
intervention where they could. Many practices recog-
nised that they were doing preventive care in an unsys-
tematic or haphazard way and not using their systems to
their full potential. Many GPs said they had been
prompted by the study to make better use of recall sys-
tems, appointment systems, reminders and prompts,
and to think of other ways to incorporate preventive evi-
dence into routine practice. Some practices could make
simple changes that quickly rectified recording prob-
lems. Other practices had begun to make much larger
changes including clinical screening by practice nurses,
40‑49 yr. health checks, and commencement of clinics
catering for 40‑49 yr. old patients. System changes such
as combining their patient data base with their appoint-
ment systems and increased referral to allied health pro-
fessionals were also common. Tools such as the
AUSDRISK and cardiovascular risk calculators were be-
ing used more routinely because of the study.
Baseline patient characteristics
Two practices were lost prior to baseline assessment:
one intervention practice was excluded because of in-
compatibility between the electronic medical record and
the data extraction program; and one control practice
withdrew citing lack of capacity to continue participating
in the study.
The patient sample was recruited from 30 practices
(15 intervention; 15 control). Fifteen percent (15%;
349 intervention; 390 control) of all patients invited
to participate consented at baseline. Of these, 589
(80%) also completed the 12-month questionnaire
(Fig. 3). We found no significant differences between
the respondents in the intervention and control prac-
tices at baseline in relation to gender, age and other
demographic variables (Table 2).
Respondents were more likely to be female (514
women versus 225 men). Most respondents were born
in Australia (75%) and spoke English at home (95%), and
were generally skilled, with 62% having a professional/
technical or higher university qualification, and 65%
being in some form of employment.
Patient outcomes
1. Patient self-reported impact on behaviour change
Most of those at-risk indicated they were ready to
change their behaviours. There was an increase in
the proportion of intervention patients in the ‘action’
or ‘maintenance’ stage of readiness to change for
eating more fruits and vegetables (from 76.7 to
82.8%), eating less fat (from 71.3 to 80.4%), and
losing weight (from 69.7 to 79.5%) (Table 3). There









No of patients 349 (47) 390 (53)
Male 114 (33) 111 (28) NS
Female 235 (67) 279 (71)
39yrsa 1 0 NS
40-49 yrs 93 (27) 101 (26)
50-59 yrs 118 (34 150 (38)
60-69 yrs 133 (38) 135 (35)
70yrsa 1 2
Missing 3 2
Mean age 55.6 yrs 55.5 yrs
English spoken at home 330 (95) 375 (96) NS
Born in Australia 263 (75) 289 (74) NS
University degree or higher 119 (34) 141 (36) NS
Technical/Professional
qualification
96 (28) 99 (25)
School leaving 123 (35) 140 (36)
Other/not specified 9 (2) 10 (3)
Missing 2 0
Employed 232 (66) 249 (64) NS
Retired 69 (20) 72 (18)
Unable to work due
to illness/disability
11 (3) 18 (5)
Looking after home/family 21 (6) 32 (8)
Unemployed 4 (1) 9 (2)
Full time education 0 3
Other 6 1
Missing 6 6
aThree patients were outside the specified age range possibly due to an error
in recording at the practice
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was no significant change for patients in control
practices. The proportion of patients reporting readi-
ness to change in relation to risky drinking increased
by approximately 40% in both groups but this was
based on low baseline numbers.
When we assessed changes in mean score for PA,
diet and BMI risk, only the diet score improved in
the intervention group (p = 0.04). Self-reported BMI
and PA risk however did not significantly change
between baseline and follow up in either group
(Table 4). There was also no significant change in
the proportion of patients who reported being at-
risk for diet, PA or weight (Table 5) and no changes
in patient reported PA, diet and BMI in multilevel
linear regression adjusted for patient age, sex, prac-
tice size and state. Data was missing for 1–2% of
these questions (no differences between intervention
and control groups).
2. Patient self-reported impact on preventative care
received
Patient reported preventive care was assessed for the
3 months prior to both baseline and follow up. The
follow up assessment took place between 3 and
6 months after the completion of the intervention.
There were no significant changes between baseline
and follow-up in either group for the number of
patients who reported either attending a GP consult-
ation, or receiving a preventive health check from
their GP in the previous 3 months (Table 6). For pa-
tients who reported attending their GP in the previous
3 months, there were no significant changes in the
proportion reporting a blood pressure, cholesterol,
glucose or weight check in either group (Table 7).
Although most patients at baseline were at
increased risk in respect to diet, physical inactivity
or weight (78.8, 44.5 and 57.7% respectively), less
than one in 6 of these patients reported that they
received advice or referral at baseline Tables 8
and 9). This did not significantly change at follow
up apart from a decline in healthy eating advice
in the control group (Table 8). A smaller
proportion of patients at baseline smoked (8.5%)
or drank alcohol at risky levels (more than 2
standard drinks in a typical day) (26.2%), and the
frequency of advice and referral also did not
change significantly for these factors.
Discussion
Many of the practices in this study recognised that they
were doing preventive care in an unsystematic or hap-
hazard way. Facilitators reported a wide variation in the
organisational ability of practices, and their capacity to
address change. During the intervention, most practices
had concentrated on improving the assessment and
recording of risk factors. Few chose to improve mecha-
nisms to promote patient education or systems to
improve referral to lifestyle-related support services.
This was duly reflected in the lack of change in patient
reported assessment, advice and referral. This may
reflect a natural link between recording and assessment
and the baseline clinical audit, unduly focusing practices
on the deficiencies of their clinical data recording, or it
simply may have required less organisational change and
was easier to implement than increasing the frequency
of advice or referral.
Table 3 Proportion of patients with risk factors in action or maintenance stage of changea
Intervention N (%; 95% CI) Control N (%; 95% CI)
Baseline Follow up Baseline Follow up
Eat more fruits or vegetables 243 (76.7%; 72.0–81.3) 207 (82.8%; 78.1–87.5) 297 (83.0%; 79.1–86.9) 226 (82.5%; 78.0–87.0)
Eat less dietary fat 226 (71.3%; 66.3–76.3) 201 (80.4%; 75.5–85.3) 279 (77.9%; 73.6–82.2) 207 (75.5%; 70.5–80.6)
Do more physical activity 194 (69.8%; 64.4–75.2) 154 (75.5%; 69.6 81.4) 230 (69.9%; 65.0–74.9) 170 (74.2%; 68.6–79.9)
Lose weight 138 (69.7%; 63.3–76.1) 124 (79.5%; 73.2–85.8) 165 (74.3%; 68.6–80.1) 125 (74.4%; 67.8–81.0)
Less alcohol 9 (9.6%; 3.6–15.5) 36 (52.9%; 41.1–64.8) 9 (9.4%; 3.5–15.2) 34 (50.7%; 38.8–62.7)
Stop smoking 7 (21.9%; 7.6–36.2) 7 (35.0%; 14.1–55.9) 10 (32.3%; 15.8–48.7) 6 (31.6%; 10.7–52.5)
aPatients in action stage (taking steps to change behaviour) or maintenance stage (have overcome some barriers to sustained change)
Table 4 Changes in mean score for PA, diet and BMI
Intervention Control
Risk factor Baseline (349) Follow up (283) Baseline (390) Follow up (306)
Mean Score (95% CI) Mean Score (95% CI) Mean diff Mean Score (95% CI) Mean Score (95% CI) Mean diff
Physical activity 3.67 (3.40–3.98) 3.85(3.56–4.15) 0.18, t = 1.4, NS 3.37 (3.13–3.63) 3.47 (3.21–3.73) 0.09, t = 08, NS
Diet 4.51 (4.10–4.94) 5.00 (4.76–5.25) 0.49, t = 2.5, p = 0.04) 4.87 (4.60–5.14) 5.05 (4.82–5.28) 0.17, t = 1.6, NS
BMI 26.40 (25.72-27.10) 26.08 (25.30-26.82) 0.32, t = 1.2, NS 26.08 (25.40-26.73) 26.34 (25.67-27.05) 0.26, t = 0.8, NS
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Although evidence supports practice facilitation as an
aid to guideline implementation in the primary care
setting, the lack of measurable impact found on pa-
tient outcomes in this study is not dissimilar to that
reported from other studies evaluating practice facili-
tation [18, 43, 44]. We found no significant difference
between the patient groups based on self-reported attend-
ance at general practice, or the recall of preventive care
received (preventive health check or measurement of
blood pressure, cholesterol, glucose or weight). Despite a
focus within the practitioner education on delivering
brief behavioural interventions based on preventive
guidelines and delivered via the 5As to patients, there
was also no difference in the frequency of patient-
recalled preventive advice or referral received for life-
style risk factors in the 3 months prior to baseline or
follow up. The impact on the reported clinical man-
agement by the GP (assessments, advice and referral)
may have been reduced because patients completed
the follow up survey at 12 months although the inter-
vention with practice was at 6 months. The frequency
of reported rates of advice was however consistent
with those reported in other larger population-based
Australian studies [29, 45].
This lack of improvement in patient behaviours and
outcomes is potentially related to several factors. It was
only possible to measure fidelity based on whether prac-
tices participated in the education and facilitation ses-
sions as intended. In this respect, there were good levels
of participation. What we were unable to measure was
the intervention enactment, or the extent to which the
clinicians applied what they had learnt through these
processes. Although the PEP intervention gave clinicians
the resources to conduct brief preventive interventions,
we do not know how frequently or effectively these were
employed with their patients. We also do not know how
well tailored their approach was to patients’ readiness to
changed or whether it was sustained over time.
We have confidence in the rationale of the interven-
tion provided to practices, however, the intervention
itself was generally of low intensity and delivered over a
relatively short time frame (4–6 months). While prac-
tices were supportive of the non-prescriptive nature of
the intervention which allowed them to choose their
own priorities, this did not translate to measurable pa-
tient change. This non-prescriptive approach to the clin-
ician component of the intervention likely influenced
fidelity and introduced variations in delivery which could
not be measured, and may have biased treatment and
impacted our interpretation of the results. When intro-
ducing behavioural type interventions there are a num-
ber of complex factors which are difficult to control
[46]. For example, the nature of the patient presentation
may have limited the opportunity to employ the 5As or
address issues of prevention, time pressures may have
cut the sessions short, the willingness of patients and/or
clinicians to discuss prevention may have varied from
day to day and the competence level of clinicians within
the trial may have varied.
Based on 2011 Australian Census data, the patient
sample in the PEP trial had both a higher proportion of
people with a tertiary education (35% versus 25%) and
speaking English at home (95% versus 76.8%) than the
general population. This may have positively influenced
the respondents’ level of engagement with, and motiv-
ation for preventive behaviours [47]. A larger proportion
of those ‘at-risk’ at both time points reported being ei-
ther in the ‘action or maintenance stages’ in relation to
diet, PA or weight. Although this provides a useful as-
sessment in terms of readiness to change, it provides
limited understanding of the mechanisms that may have
been affecting behaviour change in individuals. We
Table 5 Proportion of patients reporting PA, diet and weight risk
Proportion at-risk Baseline
349
N (%; 95% CI)
Follow up
283
N (%; 95% CI)
Baseline
390
N (%; 95% CI)
Follow up
306
N (%; 95% CI)
Physical Activity risk (<=4) 165 (47.3%; 42.0–52.5) 151 (53.4; 47.5–59.2) 164 (42.1%; 37.2–47.0) 134 (43.8%; 38.2–49.3)
Diet risk (<=6) 270 (77.4%; 73.0–81.8) 220 (77.7%; 72.9–82.6) 313 (80.0%; 76.0–84.0) 231 (75.5%; 70.7–80.3)
Weight risk (BMI > 25) 202 (57.9%; 52.7–63.1) 156 (55.1%; 49.3–60.9) 225 (57.7%; 52.8–62.6) 168 (54.9%; 49.3–60.5)
Table 6 Patient self-reported use of general practice services (All patients previous 3 months)
Intervention N (%; 95% CI) Control N (%; 95% CI)
Health service Baseline (349) Follow up (283) Baseline (390) Follow up (306)
Attended GP visit(s) 255 (73.1%; 68.4–77.7) 212 (74.9%;69.9–80.0) 292 (74.9%; 70.6–79.2) 231 (75.5%; 70.7–80.3)
0 GP visits 97 (27.8%; 23.1–32.5) 71 (25.1%; 20.0–30.1) 103 (26.4%; 22.0–30.8) 75 (24.5%; 19.7–29.3)
1–2 GP visits 184 (52.7%; 47.5–58.0) 162 (57.2%; 51.5–63.0) 227 (58.2%; 53.3–63.1) 177 (57.8%; 52.3–63.4)
3–5 GP visits 56 (16.0%; 12.2–19.9) 40 (14.1%; 10.1–18.2) 51 (13.1%; 9.7–16.4) 45 (14.7%; 10.7–18.7)
6+ GP visits 12 (3.4%; 1.5–5.4) 10 (3.5%; 1.4–5.7) 9 (2.3%; 0.8–3.8) 9 (2.9%; 1.0–4.8)
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found no significant change, for these variables over
12 months in our sample, except for a small increase in
the proportion of those in the intervention group who
were actively trying to lose weight or eat a better diet.
While individual behaviour change is a key vehicle for
improving health [48], we know that it does occur grad-
ually and with fluctuations of willingness and motivation
[49]. Readiness to change is influenced by an individual’s
level of self-efficacy (belief in their ability to change), the
specific context, and the patient–practitioner interaction
and level of communication [50].
A major strength of this trial is the rigour of the ran-
domised design. Although we recruited patients across
all participating practices, the overall response rate to
the survey was lower than expected, leaving the trial
under-powered to demonstrate small changes in lifestyle
risk behaviour. As patient invitation letters from the
practices were used to recruit patients we were also un-
able to compare the characteristics of our sample with
the characteristics of those patients who did not respond
as we have identifying and clinical information only from
consenting patients. It is possible that the patients who
chose to respond were more motivated, or more edu-
cated than those who did not respond and hence this
may have introduced response bias.
Analysis of the baseline demographic data suggests
that, compared to other data routinely collected in
Australian general practice, people from non-English
speaking backgrounds were under-represented within
our sample [51] and the level of health literacy among
the sample was relatively high [52]. We therefore
cannot make accurate judgements as to the represen-
tativeness of our sample. It is possible that the level
of health literacy among this sample may explain the
relatively high numbers reporting that they had initi-
ated change at baseline, and this may have impacted
the margin for improvement in behaviour that could
reasonably be achieved.
The patient questionnaire relied on self-reported
patient response which raises some limitations. Firstly,
patients may knowingly under-report behaviours they
feel are undesirable such as weight and other risk behav-
iours [53, 54], or misinterpret what they need to report.
Research has shown that self-report of weight is com-
monly underestimated and height overestimated, hence
calculations of BMI based on self-report may be under-
estimated [55]. Test/retest analysis of health risk factors
and self-reported chronic conditions among a sample of
people aged 16 years and over from South Australia [56]
has also found some variation with self-report of fruit
and vegetable intake. This same study states it is rea-
sonable to expect some chance variation for some
behavioural related variables such as physical activity,
smoking and alcohol consumption. To aid recall
accuracy both baseline and follow questionnaires
asked for patients to report the preventive care
received in the previous 3 months. For follow up this
was effectively the care received between months nine
and twelve. It is likely that the biggest impact on
preventive care would have occurred during and im-
mediately following the intervention and it is there-
fore possible that the intervention effect could have
Table 7 Self-reported receipt of health services (previous 3 months) for patients reporting GP visits
Intervention N (%; 95% CI) Control N (%; 95% CI)
Patients reporting GP visitsa Baseline (255) Follow up (212) Baseline (292) Follow up (231)
Preventive health check by GP 164 (64.4%; 58.4–70.2) 126 (59.4%; 52.8–66.0) 185 (63.4%; 57.8–68.9) 142 (61.5%; 55.2–67.7)
Any check by GP (BP/cholesterol/sugar/weight) 205 (80.4%; 75.5–85.3) 173 (81.6%; 76.4–86.8) 252 (86.3%; 82.4–90.2) 197 (85.3%; 80.7–89.9)
Blood pressure check by GP 255 (74.2%; 68.7–79.5) 156 (73.6%; 67.7–79.5) 237 (81.2%; 76.7–85.6) 185 (80.1%; 74.9–85.2)
Blood cholesterol check by GP 112 (43.9%; 37.8–50.0) 99 (46.7%; 40.0–53.4) 127 (43.5%; 37.8–49.2) 115 (49.8%; 43.3–56.2)
Blood sugar check by GP 52 (20.4%; 15.4–25.3) 81 (38.2%; 31.7–44.7) 79 (27.1%; 22.0–32.2) 85 (36.8%; 30.6–43.0)
Weight check by GP 52 (20.4%; 15.4–25.3) 55 (25.9%; 22.0–31.8) 79 (27.1%; 22.0–32.2) 58 (25.2%; 19.5–30.7)
aIncludes only those patients who reported seeing their GP in Table 6
Table 8 Patient self-reported frequency of advice received from their GP
Intervention N (%) (95% CI) Control N (%, 95% CI)
Type of advice/referral Baseline Follow up Baseline Follow up
Healthy eating advicea 26 (11.0%; 7.0–15.0) 30 (15.8%; 10.6–21.0) 35 (13.1%; 9.1–17.2) 12 (5.8%; 2.6–9.0)
Physical activity advice 35 (14.4%; 10.0–18.8) 32 (20.5%; 14.2–26.8) 38 (13.5%; 9.5–17.5) 21 (12.0; 7.2–16.8)
Weight advice 25 (16.0%; 10.3–21.8) 16 (12.5%; 6.8–18.2) 34 (19.1%; 13.3–24.9) 16 (12.0%; 6.5–17.6)
Smoking advice 10 (43.5%; 23.2–63.7) 7 (58.3%; 30.4–86.2) 14 (58.3%; 38.6–78.1) 3 (23.1%; 0.2–46.0)
Alcohol advice 8 (50%; 25.5–74.5) 9 (16.4%; 6.6–26.1) 14 (100%) 7 (15.9%; 5.1–26.7)
aComparison between intervention and control: Baseline X2 = 0.4, p = 0.6; Follow up X2 = 9.3, p = 0.002
Harris et al. BMC Health Services Research  (2017) 17:637 Page 11 of 14
dissipated by this point. The timing of these types of
interventions therefore comparative to their evalu-
ation is a major consideration for the design of inter-
ventions which aim to maximise sustainability.
The intervention was also insufficient to change
patient health risk behaviours. Patients who are over-
weight, smoke, drink hazardously and have poor diet
or inadequate physical activity generally know that
these factors increase their risk of chronic disease,
and they may try to change their behaviour a number
of times before they are successful [57]. It is recog-
nised that successful behaviour change may require
tailored support for people in different social circum-
stances, at different stages of disease and with differ-
ent health literacy levels [58]. Changing patient risk
behaviours therefore requires a sustained management
strategy incorporating individual assessment, goal
setting, referral or enrolment in patient education or
coaching and ongoing follow up. The lack of these
components may therefore contribute to a lack of
change in outcomes such as physical activity. Some
additional self-management tools and programs may
also be beneficial. Within general practice, strategies
need to be incorporated into everyday practice rou-
tines. Evaluating the interactions between clinicians
and patients would be valuable so we can understand
why health behaviour interventions work or don’t
work and therefore how to design them to be opti-
mally effective and efficient [58].
Conclusions
We found little impact on patient reported preventive
care and risk behaviours from this complex practice level
intervention aimed at the adoption of evidence based
prevention approaches. Achieving changes in patient be-
haviour and patient outcomes especially from a practice
level intervention is inherently easier for activities such
as assessment but much more difficult for advice, goal
setting and referral. Practice level interventions are me-
diated by uncontrollable factors and it is important to
carefully monitor changes at the level of the patient-
provider encounter. This has implications for quality im-
provement programs. Our study demonstrates some of
the challenges inherent in providing suitable chronic dis-
ease preventive interventions in general practice which
are both scalable to whole practice populations and meet
the needs of diverse practice structures.
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